Number of Patients per Cohort and Sample Size Considerations Using Dose Escalation with Overdose Control

Figure 2

Estimated mean length of HPD of the posterior distribution of the MTD as a function of the number of patients accrued to the trial for different target probabilities of DLT 𝜃.